The Growth Investor Daily Brief

Tractian, Tenstorrent, and Maze Therapeutics: Series C+ Funding Highlights

5 min · 5 dec 2024
aflevering Tractian, Tenstorrent, and Maze Therapeutics: Series C+ Funding Highlights artwork

Beschrijving

Michelle starts with an introduction and welcome, leading into the latest Series C+ funding highlights. The episode features Tractian's funding achievements, alongside updates on Tenstorrent and Maze Therapeutics. In between, there's a brief mention of the episode's sponsor, Acme Corp. Michelle wraps up with closing remarks, providing listeners with a comprehensive overview of these significant funding developments in the startup ecosystem. (0:00) Introduction and welcome (0:12) Series C+ funding highlights: Tractian, Tenstorrent, and Maze Therapeutics (3:19) Sponsor: Acme Corp (5:24) Wrap-up and closing remarks

Reacties

0

Wees de eerste die een reactie plaatst

Meld je nu aan en word lid van de The Growth Investor Daily Brief community!

Probeer gratis

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode. · Elk moment opzegbaar.

  • Podcasts die je alleen op Podimo hoort
  • 20 uur luisterboeken / maand
  • Gratis podcasts

Alle afleveringen

9 afleveringen

aflevering Axiado, ModifyHealth, Cleerly, and Tenstorrent: Series C+ Funding Highlights and Future Prospects artwork

Axiado, ModifyHealth, Cleerly, and Tenstorrent: Series C+ Funding Highlights and Future Prospects

Michelle introduces the latest episode of The Growth Investor Daily Brief, focusing on companies that have recently secured Series C+ funding. The episode highlights Axiado's Series C funding and their strategic expansion plans, along with ModifyHealth's Series C success and their outlined growth trajectory. Additionally, Cleerly's innovative AI technology and insights into their Series C funding are discussed. The episode also covers Tenstorrent's impressive Series D round, exploring their future prospects in the industry. Michelle concludes with closing remarks and a call to action, urging listeners to stay updated on the latest trends in startup funding. (0:00) Introduction to The Growth Investor Daily Brief (0:12) Companies securing Series C+ funding highlights (1:21) Axiado's Series C funding and expansion strategy (2:11) ModifyHealth's Series C success and growth plans (3:38) Cleerly's AI technology and Series C funding insights (5:26) Tenstorrent's massive Series D round and future prospects (6:56) Closing remarks and call to action

6 dec 20247 min
aflevering OneRail, Tenstorrent, and Maze Therapeutics: Series C+ Funding and Future Plans artwork

OneRail, Tenstorrent, and Maze Therapeutics: Series C+ Funding and Future Plans

Michelle welcomes listeners to the latest episode of The Growth Investor Daily Brief, diving into recent Series C+ funding updates. The episode covers OneRail's efforts in optimizing last-mile delivery and their funding plans, as well as Tenstorrent's Series D success in the AI chip sector. Additionally, Maze Therapeutics' Series D financing and their future strategic plans are discussed. The episode wraps up with investor insights, providing listeners with essential information to stay informed about the evolving investment landscape. (0:00) Welcome to The Growth Investor Daily Brief (0:13) Series C+ funding updates: OneRail, Tenstorrent, and Maze Therapeutics (0:39) OneRail's optimization of last-mile delivery and funding plans (1:21) Tenstorrent's Series D success in the AI chip sector (2:22) Maze Therapeutics' Series D financing and future plans (5:14) Investor insights and episode wrap-up

4 dec 20245 min